NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OneSkin

OneSkin

Private
San Francisco, CaliforniaConsumer & Commercehttps://www.oneskin.co/

Last Round

Series A

Extension

Aug 7, 2025

Est. Valuation

$142.31M

Total Funding Raised

$49.25M

Company Overview

OneSkin is a biotechnology company that develops and sells topical skin supplements designed to reverse skin's biological age at the molecular level.

Sector

Consumer & Commerce

Verticals

Biotechnology, Fashion & Beauty, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

longevity skincarecellular senescencepeptide skincareanti-agingDTC skincareskin longevitybiohackingscience-backed skincaresubscription skincarebiological agebiotechnologyMolClockclinical skincare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OneSkin Comparables

Compare OneSkin with similar companies based on industry and business-model similarity.

OneSkin comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

OneSkin Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionAug 7, 2025
Series AJul 1, 2025
Series ANov 13, 2024
SeedOct 26, 2022
SeedMay 8, 2017
Accelerator
Jul 1, 2016

Key People

Founding team and executive leadership

Carolina Reis Oliveira

Founder And CEO

Founding Team

Michael S. Lee

Chief Operating Officer

Executive Team

OneSkin Investors

Notable investors and investment history

OneSkin investors
InvestorRounds
Selva VenturesSeries A
Able PartnersSeries A
Plus CapitalSeries A
Metaplanet HoldingsSeries A
Prelude Growth PartnersSeries A, Series A Extension
IndieBioSeed, Accelerator
SOSVAccelerator, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Proprietary peptide claims to be first to reduce biological age of human skin.

OneSkin Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OneSkin Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OneSkin's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range63
Year Founded2016
Last FundingAug 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.